Chronic obstructive pulmonary disease • 1: Susceptibility factors for COPD the genotype-environment interaction

Thorax

Volumn 57, Issue 8, 2002, Pages 736-741

  Sandford, A J ^a   Silverman, E K ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 1 ANTITRYPSIN; CYTOCHROME P450 1A1; CYTOKINE; EPOXIDE HYDROLASE; GLUTATHIONE TRANSFERASE; HEME OXYGENASE 1; MICROSOME ENZYME; PROTEINASE; TRANSMEMBRANE CONDUCTANCE REGULATOR; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D BINDING PROTEIN;

CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; GENE MUTATION; GENETIC LINKAGE; GENOTYPE; HUMAN; IMMUNE SYSTEM; INFLAMMATION; LUNG DISEASE; LUNG FUNCTION; MUCOCILIARY CLEARANCE; PRIORITY JOURNAL; REVIEW; SPIROMETRY; XENOBIOTIC METABOLISM;

ALPHA 1-ANTITRYPSIN DEFICIENCY; ANTIOXIDANTS; ENDOPEPTIDASES; FORCED EXPIRATORY VOLUME; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; LINKAGE (GENETICS); MUTATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; VITAL CAPACITY;

EID: 0036346760     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.57.8.736     Document Type: Review

References (93)

1. The interaction of nature and nurture
2. Some methods of analysing genotype-environment interaction
3. Amplification of inflammation in emphysema and its association with latent adenoviral infection
4. Risk factors for the development of chronic obstructive pulmonary disease
5. Alpha 1 antitrypsin deficiency: The clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z. A survey by the British Thoracic Association
6. 1-antitrypsin deficiency
7. Natural history and life expectancy in severe alpha1-antitrypsin deficiency, Pi Z
8. 1 related to smoking status in individuals with severe alpha1-antitrypsin deficiency (PiZZ)
9. Variability of pulmonary function in alpha-1-antitrypsin deficiency: Clinical correlates
10. Family study of alpha 1-antitrypsin deficiency: Effects of cigarette smoking, measured genotype, and their interaction on pulmonary function and biochemical traits
11. 1 among patients with severe hereditary alpha 1-antitrypsin deficiency type PiZ
12. Survival in relation to lung function and smoking cessation in patients with severe hereditary alpha 1-antitrypsin deficiency
13. 1-antitrypsin deficiency in nonsmokers
14. Effect of age and occupational exposure to airway irritants on lung function in non-smoking individuals with alpha 1-antitrypsin deficiency (PiZZ)
15. Environmental correlates of impaired lung function in non-smokers with severe alpha 1-antitrypsin deficiency (PiZZ)
16. Occupational exposure risks in individuals with PI*Z alpha(1)-antitrypsin deficiency
17. Genotypic and phenotypic similarities in pulmonary function among family members of adult monozygotic and dizygotic twins
18. Genetic and environmental determinants of chronic obstructive pulmonary disease
19. A common familial component in lung cancer and chronic obstructive pulmonary disease
20. Chronic obstructive pulmonary disease: A challenge in genetic epidemiology
21. Familial prevalence of chronic obstructive pulmonary disease in a matched pair study
22. Familial occurrence of chronic respiratory disease and familial resemblance in ventilatory capacity
23. Studies of the familial aggregation of chronic bronchitis and obstructive airways disease
24. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis
25. Bronchodilator responsiveness and serum total IgE levels in families of probands with severe early-onset COPD
26. Major genetic mechanisms in pulmonary function
27. Evidence for major genes influencing pulmonary function in the NHLBI Family Heart Study
28. Segregation analysis of two lung function indices in a random sample of young families: The Humboldt Family Study
29. Segregation analysis of pulmonary function among families in the Framingham Study
30. Genome wide linkage analysis of quantitative spirometric phenotypes in severe early-onset chronic obstructive pulmonary disease
31. Genome-wide linkage analysis of severe, early-onset chronic obstructive pulmonary disease: Airflow obstruction and chronic bronchitis phenotypes
32. 1-antitrypsin deficiency
33. PI SZ phenotype in chronic obstructive pulmonary disease
34. Genetic risk factors for chronic obstructive pulmonary disease
35. Heterozygosity in the Pi-system as a pathogenetic cofactor in chronic obstructive pulmonary disease (COPD)
36. Risk of hospital admission for obstructive pulmonary disease in alpha(1)-antitrypsin heterozygotes of phenotype PiMZ
37. Molecular diagnosis of intermediate and severe alpha(1)-antitrypsin deficiency: MZ individuals with chronic obstructive pulmonary disease may have lower lung function than MM individuals
38. 1-antitrypsin gene are associated with chronic obstructive airways disease
39. 1-antitrypsin gene region in patients with chronic obstructive pulmonary disease
40. 1-antitrypsin gene and chronic obstructive pulmonary disease
41. 1-antichymotrypsin mutations in patients with obstructive pulmonary disease
42. 1-antitrypsin gene associated with chronic respiratory disease occurs in a regulatory sequence
43. 1-antitrypsin enhancer results in an interleukin-6 deficient acute-phase response due to loss of cooperativity between transcription factors
44. 1-antitrypsin genotypes and the acute-phase response to open heart surgery
45. 1-antitrypsin deficiency alleles and the Taq-I G→A allele in cystic fibrosis lung disease
46. 1-antichymotrypsin gene associated with chronic lung disease
47. 1-antichymotrypsin mutations in patients with chronic obstructive pulmonary disease
48. Association between alpha-1-antichymotrypsin polymorphism and susceptibility to chronic obstructive pulmonary disease
49. Human microsomal epoxide hydrolase: Genetic polymorphism and functional expression in vitro of amino acid variants
50. Interindividual and interspecies variation in hepatic microsomal epoxide hydrolase activity: Studies with cis-stilbene oxide, carbamazepine 10, 11-epoxide and naphthalene
51. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema
52. Microsomal epoxide hydrolase genotypes and chronic obstructive pulmonary disease in Japanese
53. Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: Combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and T1
54. Susceptibility genes for rapid decline of lung function in the Lung Health Study
55. Frequency of glutathione S-transferase M1 deletion in smokers with emphysema and lung cancer
56. Peculiarities of the GSTM1 0/0 genotype in French heavy smokers with various types of chronic bronchitis
57. Heterogeneous expression and polymorphic genotype of glutathione S-transferases in human lung
58. Differences in the catalytic efficiencies of allelic variants of glutathione transferase P1-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons
59. Glutathione S-transferase P1 [GSTP1) polymorphism in patients with chronic obstructive pulmonary disease
60. Protective effects of heme oxygenase-1 in acute lung injury
61. Heme oxygenase-1: Function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury
62. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema
63. d(TG)n.d(CA)n sequences upstream of the rat prolactin gene form Z-DNA and inhibit gene transcription
64. Secretion of tumour necrosis factor α and lymphotoxin α in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease
65. Tumor necrosis factor-α gene polymorphism in chronic bronchitis
66. Association of tumor necrosis factor alpha gene promoter polymorphism with the presence of chronic obstructive pulmonary disease
67. Neither IL-1 beta, IL-1 receptor antagonist, nor TNF-alpha polymorphisms are associated with susceptibility to COPD
68. Tumour necrosis factor-alpha gene promoter polymorphism in chronic obstructive pulmonary disease
69. CFTR gene variant IVS8-5T in disseminated bronchiectasis
70. Complete mutational screening of the CFTR gene in 120 patients with pulmonary disease
71. CFTR gene mutations - Including three novel nucleotide substitutions - And haplotype background in patients with asthma, disseminated bronchiectasis and chronic obstructive pulmonary disease
72. Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation
73. Gene-environment interaction and affected sib pair linkage analysis
74. Invited commentary: On studying the joint effects of candidate genes and exposures
75. Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: Case-control studies with no controls!
76. Limitations of the case-only design for identifying gene-environment interactions
77. Association between the CYP1A1 gene polymorphism and susceptibility to emphysema and lung cancer
78. Risk factors in chronic obstructive pulmonary disease (COPD)
79. Risk factors associated with longitudinal change in pulmonary function
80. Factors associated with the change in ventilatory function and the development of chronic obstructive pulmonary disease in a 13 year follow-up of the Cracow study. Risk of chronic obstructive pulmonary disease
81. Is ABH nonsecretor status a risk factor for obstructive lung disease?
82. Genetic markers in chronic air-flow limitation: A genetic epidemiologic study
83. ABO, Lewis and secretor status and relative incidence of airflow obstruction
84. 1, wheezing, and asthma
85. Analysis of HLA antigens in patients with diffuse panbronchiolitis
86. Contribution of HLA genes to genetic predisposition in diffuse panbronchiolitis
87. Possible protective effect against chronic obstructive airways disease by the GC 2 allele
88. Vitamin D binding protein variants and the risk of COPD
89. Impaired lung function in patients with IgA deficiency and low levels of IgG2 or IgG3
90. Immunoglobulin G subclasses and spirometry in patients with chronic obstructive pulmonary disease
91. Selective immunoglobulin A deficiency and chronic obstructive lung disease. A family study